Palvella Therapeutics PVLA
NASDAQ PVLA
$137.93 -1.07 (-0.77%)
At close: Sep 30, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) EV to CFO (2017 - 2024)

Updated

Palvella Therapeutics' (PVLA) EV to CFO was 0.17 for Q3 2024.

Analysis

Palvella Therapeutics (PVLA) EV to CFO (2017 - 2024) Analysis & Trends

For FY2017, EV to CFO at Palvella Therapeutics was 545.04.

  • The Q3 2024 figure ranks as the highest quarterly EV to CFO since Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Palvella Therapeutics 1.99 Bn 1.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 0.17
Jun 30, 2024 -0.84
Sep 30, 2018 7,314.06
Jun 30, 2018 411.58
Mar 31, 2018 529.42
Dec 31, 2017 545.04
Sep 30, 2017 429.81
Jun 30, 2017 1,978.51
Mar 31, 2017 951.32
API Access

Palvella Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PVLA&period=max&api_key=YOUR_API_KEY